Erythema: Clinical Trials

110 completed, 24 unknown, 13 terminated, 11 recruiting. 84 Not applicable, 28 Phase 2, 21 Phase 1, 17 Phase 3, 14 Phase 4.

By phase and status

Phase	Trials	Status
Not applicable	84	Completed 57, Unknown 11, Terminated 5, Not yet recruiting 4, Recruiting 3, Withdrawn 3, Enrolling by invitation 1
Phase 2	28	Completed 11, Terminated 5, Withdrawn 4, Active not recruiting 3, Unknown 3, Not yet recruiting 1, Recruiting 1
Phase 1	21	Completed 11, Withdrawn 3, Not yet recruiting 2, Terminated 2, Unknown 2, Recruiting 1
Phase 3	17	Completed 11, Terminated 2, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 4	14	Completed 7, Recruiting 2, Withdrawn 2, Not yet recruiting 1, Terminated 1, Unknown 1
Early Phase 1	2	Recruiting 1, Unknown 1

Follow Erythema: new trials by email Literature Review of Erythema trials Research Report on Erythema

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis Site specific standard of care comparison - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis		Withdrawn	Massachusetts General Hospital		2030-01-01	2026-01-16
TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 Years TRIDERM D.S. Crema Normalizzante - Cradle Cap, Seborrheic Dermatitis	Not applicable	Not yet recruiting	ICIM International S.r.l.	20	2026-10-01	2026-10-06
Subconjunctival Humira for Boston Keratoprosthesis Adalimumab Injection - Penetrating Keratoplasty, Multiple Graft Failure	Phase 1	Not yet recruiting	Massachusetts Eye and Ear Infirmary	8	2026-10-01	2026-08-31
Comparison of Segmental Body Composition Characteristics in Lipedema and Obesity Bioelectrical Impedance Analysis, Numeric Rating Scale, Lower Extremity Functional Scale - Lipedema, Obesity		Recruiting	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey	200	2026-09-20	2026-10-16
A Clinical Study to Evaluate the Efficacy and SPF of Two Test Materials According to an Adaptation of the Guidelines of the FDA Sunscreen Drug Products for Over-the-Counter Human Use Hybrid sunscreen, Chemical sunscreen, No sunscreen - Epidermis, Ultraviolet Exposure	Phase 4	Recruiting	Good Molecules, LLC	60	2026-09-14	2026-08-27
Investigation of Systemic Inflammation Markers in Lipedema Clinical parameters, Laboratory parameters - Lipedema, Inflamation		Completed	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey	192	2026-06-01	2026-08-26
Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris Timolol 0.5% Ophthalmic Solution, Intense Pulsed Light - Post Inflammtory Erythema, Acne Vulgaris	Early Phase 1	Recruiting	Pham Ngoc Thach University of Medicine	60	2026-03-09	2026-04-01
HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness HLA-B*58:01 Genotyping, Allopurinol Tablet, Febuxostat - Gout Initiating Urate-loweringUrate-lowering Therapy, Gout Arthritis	Phase 4	Not yet recruiting	Haiphong University of Medicine and Pharmacy	228	2026-01-20	2026-01-27
Skin Barrier Function in Women Using UV Nail Lamps Healthy Volunteers		Completed	University of Split, School of Medicine	40	2026-01-12	2026-10-06
The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin Parameters CPMSM-HD, CPMSM-LD, Placebo - Erythema, Telangiectasis	Not applicable	Not yet recruiting	VIST - Faculty of Applied Sciences	90	2026-01-01	2026-01-15
Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration MB Luxury Skincare containing Epigallocatechin Gallate (EGCG) - Hyperpigmentation, Dry Skin	Phase 2 / Phase 3	Completed	Naniek Widyaningrum	300	2025-12-01	2026-07-27
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies. DARATUMUMAB (DARZALEX®) - Toxic Epidermal Necrolysis, Immunotherapy	Phase 1 / Phase 2	Not yet recruiting	Hospices Civils de Lyon	9	2025-10-29	2025-08-07
Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks RV4421B- EV0407 - Atopic Dermatitis	Not applicable	Recruiting	Pierre Fabre Dermo Cosmetique	105	2025-09-30	2026-05-05
Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea Intense Pulsed Light (IPL) - Lumecca, Rosacure anti-redness dermocosmetic regimen - Rosacea	Not applicable	Completed	Medical University of Silesia	60	2025-09-29	2026-07-27
Effect of Red and Blue Light Irradiation on Postoperative Wound Healing in Perianal Absces Red light exposure, Red-blue light exposure - Perianal Abscess	Not applicable	Not yet recruiting	The Affiliated Hospital of Putian University	222	2025-09-15	2025-09-04
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS)		Recruiting	Leiden University Medical Center	840	2025-07-29	2025-08-19
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis)) Amoxicillin + Saccharomyces boulardii CNCM I-745, Amoxicillin + Placebo, Stool samples - Erythema Migrans of Lyme Disease	Phase 4	Recruiting	Biocodex	120	2025-07-16	2025-08-27
Test Serum Clinical Study HA injection, Facial serum application - Redness	Not applicable	Completed	ChinaNorm	90	2025-06-23	2025-11-17
Autologous Serum Obtained by a Closed-Circuit Collection Device Autologous Serum 20% - GVHD, Meibomian Gland Dysfunction (Disorder)	Phase 2	Active not recruiting	GIANCARLO FATOBENE	16	2025-06-20	2026-10-21
Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris Dapsone 7.5% gel, Vehicle gel - Acne Vulgaris	Phase 4	Completed	Oya Helin Dundar	100	2025-06-17	2026-05-22

Showing 20 of 182. Sign in to see all of them.

Narrower conditions

Stevens-Johnson Syndrome (40)  ·  Rosacea (16)  ·  Erythema Multiforme (15)  ·  Edema (10)  ·  Pruritus (7)  ·  Dry Eye Syndromes (6)  ·  Erythema Chronicum Migrans (6)  ·  Sunburn (6)  ·  Telangiectasis (6)  ·  Dermatitis (5)  ·  Pain (5)  ·  Pemphigoid, Benign Mucous Membrane (5)  ·  Acne Vulgaris (4)  ·  Breast Neoplasms (4)

Broader conditions

Skin and Connective Tissue Diseases (182)  ·  Skin Diseases (180)  ·  Pathological Conditions, Signs and Symptoms (130)  ·  Signs and Symptoms (123)  ·  Skin Manifestations (117)  ·  Skin Diseases, Vesiculobullous (54)  ·  Immune System Diseases (51)  ·  Dermatitis (47)  ·  Hypersensitivity (47)  ·  Mouth Diseases (46)  ·  Stomatognathic Diseases (46)  ·  Chemically-Induced Disorders (42)  ·  Hypersensitivity, Delayed (41)  ·  Stomatitis (41)

Interventions

Doxycycline (4)  ·  Gels (3)  ·  Infliximab (3)  ·  Amoxicillin (2)  ·  Brimonidine Tartrate (2)  ·  Clobetasol (2)  ·  Dapsone (2)  ·  Filgrastim (2)  ·  Immunoglobulins, Intravenous (2)  ·  Intense Pulsed Light Therapy (2)  ·  Metronidazole (2)  ·  Oxymetazoline (2)  ·  Sodium Chloride (2)  ·  bilastine (2)  ·  tofacitinib (2)

Sponsors

Allergan (7)  ·  Church & Dwight Company, Inc. (6)  ·  ChinaNorm (4)  ·  University Medical Centre Ljubljana (4)  ·  University of California, Davis (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Bayer (3)  ·  Galderma R&D (3)  ·  Massachusetts Eye and Ear Infirmary (3)  ·  Northwestern University (3)  ·  Chulalongkorn University (2)  ·  Faes Farma, S.A. (2)  ·  Hasanuddin University (2)  ·  Hospices Civils de Lyon (2)  ·  L'Oreal (2)

Countries

United States (68)  ·  China (11)  ·  Germany (9)  ·  Brazil (6)  ·  France (6)  ·  Slovenia (6)  ·  Canada (4)  ·  Indonesia (4)  ·  Switzerland (4)  ·  Taiwan (4)  ·  Thailand (4)  ·  Turkey (Türkiye) (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Italy (3)

Top investigators

Dennis P West, PhD (2)  ·  James Chodosh, MD, MPH (2)  ·  Pinnita Prabhasawat, MD (2)  ·  Raja Sivamani, MD (2)  ·  Ajibole Abatunde, MD (1)  ·  Alexander Navarini, MD (1)  ·  Alexander de Vries, MD (1)  ·  Ana Checa-Ros, MD, PhD (1)  ·  Ananias Diokno, MD (1)  ·  Andrea L Tsai, MD (1)  ·  Andrew King (1)

Results publications

PMID 30075748, PMID 12558848, PMID 15161841, PMID 15287367, PMID 19860762, PMID 20981308, PMID 22269230, PMID 22431712, PMID 22523260, PMID 24048361, PMID 24075057, PMID 25173772, PMID 26140969, PMID 26297574, PMID 26416154, PMID 26794701, PMID 27106261, PMID 28343667, PMID 28476287, PMID 28552284, PMID 29153745, PMID 29233132, PMID 29478292, PMID 29505880, PMID 29569311, PMID 29800753, PMID 30116702, PMID 30346532, PMID 30955941, PMID 31542406, PMID 31867125, PMID 32095992, PMID 32373450, PMID 32643266, PMID 32888514, PMID 32893100, PMID 32955913, PMID 33185716, PMID 33955844, PMID 34233378, PMID 34463403, PMID 34734507, PMID 35072138, PMID 35229002, PMID 35768278, PMID 36175092, PMID 36209759, PMID 36277123, PMID 37086614, PMID 37678574

NIH funding

2009 (1), 2015 (1), 2016 (1), 2017 (1), 2023 (1), 3UM1AI068614-14S1 (1), R01AG038673 (1), R44CA224658 (1)